This site contains promotional information intended only for healthcare professionals resident in the United Kingdom

Visit Pfizer Medical siteSearch

Menu

Close

Sign In or RegisterLog Out
Pfizer MedicinesTherapy AreasExplore ContentEventsVideosMaterialsFeatured ArticlesLet’s ConnectSupplyOff-contract claimsAlliance Healthcare

Example content

Menu

Close

AMSAMSAn introduction to antimicrobial stewardshipStewardshipSurveillanceRace against resistanceABSABSABS in practice Educational ResourcesAFSAFSShape the futureAFS in practiceImplementing an AFS programmeDiagnosticsGuidelinesCase studiesAll case studiesOur CommitmentOur CommitmentOur commitment to anti-infectivesHeritageSustainability
Our work in the community
Support & ResourcesSupport & ResourcesVideosMaterialsOnline LearningOnline LearningHomeINSPIRE To: Change the CourseLondon AMS SeriesNorth West England AMS SeriesInfectious Thinking Podcasts

Information on how to access prescribing information and adverse event reporting can be found at the bottom of the page.

Online Learning
INSPIRE To: Change the Course

Welcome to INSPIRE To: Change the Course online learning. This is a 4 part series on the advances in the management of serious bacterial and invasive fungal infections in a post COVID-19 era.

Together with a group of leading experts in antimicrobial stewardship, we have developed a series of presentations and workshops designed to provide you with the knowledge and confidence to manage invasive bacterial and fungal infections and implement changes to support antimicrobial stewardship. After completing each course in the series, you will be able to download a certificate of completion with 1 CPD accreditation per course from the The Royal College of Pathologists. 

Start browsing the courses below to begin your online learning, and your journey to Change the Course.
 

Dr. Luke Moore
How to optimise antimicrobial stewardship for Gram-negative infections in the post COVID-19 era  

From this course you will learn:

  • How COVID-19 affected rates of infection
  • Challenges you may face implementing an antimicrobial stewardship programme and how to overcome them
  • How to re-work diagnostic pathways to ensure the timeliness of results
  • How to optimise antimicrobial stewardship for patients with Gram negative infections
Total time to complete: 45 minutesStart LearningLoading
Fran Garraghan
Increasing the priority level of antimicrobial stewardship
 

From this course you will learn:

  • The behaviours and characteristics required for running an  antimicrobial stewardship programme 
  • Where you are on your antimicrobial stewardship journey and how to move forward
  • What you can do to improve your AMS leadership skills
Total time to complete: 30 minutes
Start Learning
Loading
Dr. Neil Stone
Optimising the diagnosis and management of invasive fungal disease  

From this course you will learn:

  • When to consider a patient may be at risk of an invasive fungal infection 
  • The diagnostics available to you
  • How to understand the different serum biomarkers
  • The importance of bronchoalveolar lavage (BAL)
  • The benefits of oral treatment 
Total time to complete: 50 minutesStart LearningLoading
Lewis White
A diagnostic driven approach to fungal infections

Coming soon

 Start your learning now

Begin the first video in the series: "How to optimise antimicrobial stewardship for Gram-negative infections in the post COVID-19 era"
(17 minutes)
 

Go to videoLoadingAccess more antimicrobial stewardship resources

Get further information on antimicrobial stewardship including a variety of resources for antibacterial and antifungal stewardship on the Anti-infectives section of PfizerPro 
 

Visit Anti-infectivesLoading

ABS, antibacterial stewardship; AFS, antifungal stewardship; AMS, antimicrobial stewardship ; R&D, research and development.

Prescribing Information:

Click here for CRESEMBA® (isavuconazole)

Click here for ZAVICEFTA® (ceftazidime and avibactam) 

PP-CRB-GBR-1889. April 2023.

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search 

for MHRA Yellow Card in Google Play or Apple App Store

 

Adverse events should also be reported to Pfizer Medical Information on 01304 616161

PfizerPro Account

To access further materials, resources and receive communication about medicines and vaccines promoted by Pfizer.

Sign In or RegisterAccountSign Out

This site is intended only for healthcare professionals resident in the United Kingdom. If you are a member of the public wishing to access information on a specific medicine, please visit www.medicines.org.uk/emc

 

This website is brought to you by Pfizer Limited, a company registered in England 

and Wales under No. 526209 with its registered office at Ramsgate Road, Sandwich, Kent, CT13 9NJ

 

Copyright © 2023 Pfizer Limited. All rights reserved.

 

VAT registration number GB201048427

PP-UNP-GBR-4885. May 2023
For UK Healthcare Professionals*

These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.

I confirm that I am a healthcare professional* resident in the United Kingdom.

If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.

*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.

PP-PFE-GBR-3863. November 2021

YesNo
You are now leaving PfizerPro​​​​​
​
​​​​​​​You are now leaving www.pfizerpro.co.uk. Links to external websites are provided as a resource to the viewer. This website is neither owned or controlled by Pfizer Ltd. 

Pfizer accepts no responsibility for the content or services of the linked site.​​​​​​​​​​​​​​

​​​​​​​PP-PFE-GBR-3858. November 2021​​​​​​​
​​​​​​​
You are now leaving PfizerPro
​​​​​​​
​​​​​​​You are now leaving www.pfizerpro.co.uk. Links to external websites are provided as a resource to the viewer. This website is neither owned nor controlled by Pfizer Ltd. 

Pfizer accepts no responsibility for the content or services of the linked site other than the information or other materials relating to ​​​​​Pfizer medicines or 
business which it has provided or reviewed.

PP-PFE-GBR-3859. November 2021
​​​​​​​